Market Overview

CVSI NOTICE: Rosen Law Firm Reminds CV Sciences, Inc. Investors of Important Deadline in Suit – CVSI

Share:

Rosen Law Firm, a global investor rights law firm, reminds purchasers of
the securities of CV Sciences, Inc. (OTC:CVSI) from June 19, 2017
through August 20, 2018, inclusive (the "Class Period") of the important
October 23, 2018 lead plaintiff deadline in the class action. The
lawsuit seeks to recover damages for CV Sciences investors under the
federal securities laws.

To join the CV Sciences class action, go to https://www.rosenlegal.com/cases-1405.html
or call Phillip Kim, Esq. or Zachary Halper, Esq. toll-free at
866-767-3653 or email pkim@rosenlegal.com
or zhalper@rosenlegal.com
for information on the class action.

NO CLASS HAS YET BEEN CERTIFIED IN THE ABOVE ACTION. UNTIL A CLASS IS
CERTIFIED, YOU ARE NOT REPRESENTED BY COUNSEL UNLESS YOU RETAIN ONE. YOU
MAY RETAIN COUNSEL OF YOUR CHOICE. YOU MAY ALSO REMAIN AN ABSENT CLASS
MEMBER AND DO NOTHING AT THIS POINT. AN INVESTOR'S ABILITY TO SHARE IN
ANY POTENTIAL FUTURE RECOVERY IS NOT DEPENDENT UPON SERVING AS LEAD
PLAINTIFF.

According to the lawsuit, defendants during the Class Period made
materially false and/or misleading statements and/or failed to disclose
that: (1) CV Sciences received a non-final rejection from the U.S.
Patent Trademark Office ("USPTO") on April 27, 2017 regarding its
principal pharmaceutical product, CVSI-007; (2) CV Sciences received a
final rejection from the USPTO on December 14, 2017 regarding CVSI-007;
and (3) as a result of the foregoing, defendants' statements about CV
Sciences' business, operations, and prospects, were materially false
and/or misleading and/or lacked a reasonable basis. When the true
details entered the market, the lawsuit claims that investors suffered
damages.

A class action lawsuit has already been filed. If you wish to serve as
lead plaintiff, you must move the Court no later than October 23, 2018.
A lead plaintiff is a representative party acting on behalf of other
class members in directing the litigation. If you wish to join the
litigation, go to https://www.rosenlegal.com/cases-1405.html
or to discuss your rights or interests regarding this class action,
please contact Phillip Kim, Esq. or Zachary Halper, Esq. of Rosen Law
Firm toll free at 866-767-3653 or via e-mail at pkim@rosenlegal.com
or zhalper@rosenlegal.com.

Follow us for updates on LinkedIn: https://www.linkedin.com/company/the-rosen-law-firm
or on Twitter: https://twitter.com/rosen_firm.

Rosen Law Firm represents investors throughout the globe, concentrating
its practice in securities class actions and shareholder derivative
litigation. Rosen Law Firm was Ranked No. 1 by ISS Securities Class
Action Services for number of securities class action settlements in
2017. The firm has been ranked in the top 3 each year since 2013.
Attorney Advertising. Prior results do not guarantee a similar outcome.

View Comments and Join the Discussion!